Endoscopy in patients with implanted electronic devices

Gastrointestinal Endoscopy

Volumn 65, Issue 4, 2007, Pages 561-568

  Petersen, Bret T ^b   Hussain, Nadeem ^b   Marine, Joseph E ^a   Trohman, Richard G ^a   Carpenter, Steven ^b   Chuttani, Ram ^b   Croffie, Joseph ^b   DiSario, James ^b   Chotiprasidhi, Poonputt ^b   Liu, Julia ^b   Somogyi, Lehel ^b  

^a Heart Rhythm Society Representative   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; FLOXURIDINE; NARCOTIC AGENT; PROSTACYCLIN;

ARTICLE; CAUTERIZATION; COMPUTER PROGRAM; DEVICE; ELECTRIC POTENTIAL; ELECTROMAGNETIC FIELD; ELECTRONICS; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMPLANT; INFUSION PUMP; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT PLANNING;

DEFIBRILLATORS, IMPLANTABLE; ELECTROCOAGULATION; ELECTRODES, IMPLANTED; ELECTROMAGNETIC FIELDS; ELECTRONICS, MEDICAL; ENDOSCOPY, GASTROINTESTINAL; EQUIPMENT SAFETY; HUMANS; INFUSION PUMPS, IMPLANTABLE; PACEMAKER, ARTIFICIAL; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33947389713     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.09.001     Document Type: Article

References (48)

1. Hirota W.K., Petersen K., Baron T.H., et al. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 58 (2003) 475-482
2. Ginsberg G.G., Barkun A., Bosco J., et al. Wireless capsule endoscopy. Gastrointest Endosc 56 (2002) 621-624
3. Chotiprasidhi P., Liu J., Carpenter S., et al. ASGE technology status evaluation report: wireless esophageal pH monitoring system. Gastrointest Endosc 62 (2005) 485-487
4. Slivka A., Bosco J., and Barkun A. Electrosurgical generators. Gastrointest Endosc 58 (2003) 656-660
5. American Society for Gastrointestinal Endoscopy. Polypectomy devices. Gastrointest Endosc 2007. In press.
6. Ginsberg G.G., Barkun A.N., Bosco J.J., et al. The argon plasma coagulator. Gastrointest Endosc 55 (2002) 811-814
7. Nelson D.B., Barkun A.N., Block K.P., et al. Endoscopic hemostatic devices. Gastrointest Endosc 54 (2001) 833-840
8. Sager D.P. Current facts on pacemaker electromagnetic interference and their application to clinical care. Heart Lung 16 (1987) 211-221
9. Betra Y.K., and Bali I.M. Effect of coagulating current and cutting current on a demand pacemaker during transurethral resection of the prostate. A case report. Can Anaesth Soc J 25 (1978) 65-66
10. Madigan J.D., Choudhri A.F., Chen J., et al. Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 230 (1999) 639-647
11. Pinski S.L., and Trohman R.G. Interference in implanted cardiac devices, Part I. Pacing Clin Electrophysiol 25 (2002) 1367-1381
12. Pinski S.L., and Trohman R.G. Interference in implanted cardiac devices, Part II. Pacing Clin Electrophysiol 25 (2002) 1496-1509
13. Hayes DL, Strathmore NF. Electromagnetic interference with implantable devices. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical cardiac pacing and defibrillation, 2nd ed. Philadelphia: Saunders; 2000.
14. Bourke M.E. The patient with a pacemaker or related device. Can J Anaesth 43 (1996) R24-R32
15. Levine P., Balady G., Lazar H., et al. Electrocautery and pacemakers: management of the paced patient subject to electrocautery. Ann Thorac Surg 41 (1986) 313-317
16. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Available at: http://www.acc.org/qualityandscience/clinical/guidelines/pacemaker/index .htm. Accessed Sept 18, 2006.
17. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
18. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
19. DiMarco J.P. Implantable cardioverter-defibrillators. N Engl J Med 349 (2003) 1836-1847
20. Ito S., Shibata H., Okahisa T., et al. Endoscopic therapy using monopolar and bipolar snare with a high frequency current in patients with a pacemaker. Endoscopy 26 (1994) 270
21. Tanigawa K., Yamashita S., Maeda Y., et al. Endoscopic polypectomy for pacemaker patients. Chin Med J (Engl) 108 (1995) 579-581
22. Mangar D., Atlas G., and Kane P. Electrocautery pacemaker malfunction during surgery. Can J Anaesth 38 (1991) 616-618
23. Samain E., Marty J., Souron V., et al. Intraoperative pacemaker malfunction during a shoulder arthroplasty. Anesthesiology 93 (2000) 306-307
24. Heller L.I. Surgical electrocautery and the runaway pacemaker syndrome. Pacing Clin Electrophysiol 13 (1990) 1084-1085
25. Peters R.W., and Gold M.R. Reversible prolonged pacemaker failure due to electrocautery. J Interv Card Electrophysiol 2 (1998) 343-344
26. Kellow N. Pacemaker failure during transurethral resection of the prostate. Anaesthesia 48 (1993) 136-138
27. Wong D.T., and Middleton W. Electrocautery-induced tachycardia in a rate-responsive pacemaker. Anesthesiology 94 (2001) 710-711
28. Orland H.J., and Jones D. Cardiac pacemaker induced ventricular fibrillation during surgical diathermy. Anaesth Intensive Care 3 (1975) 321-326
29. Andrade A.J., and Grover M.L. Cardiac arrest from the use of diathermy during total hip arthroplasty in a patient with an external pacemaker. Ann R Coll Surg Engl 79 (1997) 69-70
30. Casavant D., Haffajee C., Stevens S., et al. Aborted implantable cardioverter-defibrillator shock during facial electrosurgery. Pacing Clin Electrophysiol 21 (1998) 1325-1326
31. Gedes L.A., Tacker W.A., and Cabler P. A new electrical hazard associated with electrocautery. Med Instrum 9 (1975) 112-113
32. Nercessian O.A., Wu H., Nazarian D., et al. Intraoperative pacemaker dysfunction caused by the use of electrocautery during a total hip arthroplasty. J Arthroplasty 13 (1998) 599-602
33. Wilson J.H., Lattner S., Jacob R., et al. Electrocautery does not interfere with the function of the automatic implantable cardioverter defibrillator. Ann Thorac Surg 51 (1991) 225-226
34. Fiek M., Dorwarth U., Durchlaub I., et al. Application of radiofrequency energy in surgical and interventional procedures: are there interactions with ICDs?. Pacing Clin Electrophysiol 27 (2004) 293-298
35. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 103 (2005) 186-198
36. Rasmussen M.J., Freidman P.A., Hammill S.C., et al. Unintentional deactivation of implantable cardioverter-defibrillators in health care settings. Mayo Clin Proc 77 (2002) 855-859
37. Goldschlager N., Epstein A., Friedman P., et al. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med 161 (2001) 649-655
38. Hauser R.G., and Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 4 (2004) 399-405
39. Questions and answers about Activa Parkinson's disease therapy (2004), Medtronic, Minneapolis (MN). http://www.medtronic.com/neuro/parkinsons/activa_qa.html . Accessed Sept 18, 2006
40. Koller W., Pahwa R., Busenbark K., et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42 (1997) 292-299
41. US Food and Drug Administration. Enterra Therapy System (formerly named Gastric Electrical Stimulation [GES] System). Available at: http://www.fda.gov/cdrh/ode/H990014sum.html. Accessed Sept 18, 2006.
42. Medtronic Entera Therapy 3116. Gastric electrical stimulation system technical manual 2002. Minneapolis (MN): Medtronic Inc; 2002.
43. Weaver J., Kim S.J., Lee M.H., et al. Cutaneous electrosurgery in a patient with a deep brain stimulator. Dermatol Surg 25 (1999) 415-417
44. Martinelli P.T., Schulze K.E., and Nelson B.R. Mohs micrographic surgery in a patient with a deep brain stimulator: a review of the literature on implantable electrical devices. Dermatol Surg 30 (2004) 1021-1030
45. US Food and Drug Administration. Adverse event report. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Detail.cfm?MDR FOI__ID=349768. Accessed Sept 18, 2006.
46. Medtronic Soletra neurostimulator for deep brain stimulation physician and hospital staff manual Rx only. Available at: www.medtronic.com/physician/neurology.html. Accessed January 27, 2007.
47. Medtronic Inc. Medtronic diagnostic and therapies for your patient. Available at: www.medtronic.com/physician/gastroenterology.html. Accessed January 27, 2007.
48. Synchromed II pump. System components clinical reference manual (2004), Medtronic, Minneapolis p. 11